Clinical Observation Of Chuanxin Tong Prescription Directional Permeation In The Treatment Of Diabetic Peripheral Neuropathy (Yang Deficiency Blood Stasis)

Objective:The clinical efficacy of Chuanxin Tong Prescription directional diabetic diagonal permeation therapy in the treatment of diabetic peripheral neuropathy(yang deficiency blood stasis)was observed,in order to guide clinicians in the treatment of diabetic peripheral neuropathy(yang deficiency blood stasis)and enrich clinical treatment methods.Methods:In this project,72 patients diagnosed with diabetic peripheral neuropathy who were hospitalized in the Department of Endocrinology of Changchun Hospital of Traditional Chinese Medicine from January 2021 to January 2022 were selected,and 72 patients were randomly divided into 2 groups,the experimental group and the control group,all the patients enrolled in diabetic peripheral neuropathy had medical nutrition therapy,the control group received conventional insulin hypoglycemic combined with methylcobalamin 0.5 mg,oral standard therapy 3 times a day,and the experimental group added Chuanxin tong prescription directional permeation treatment on the basis of the control group.The acupuncture points for treatment are Zusanli,Sanyin Sex,and Weizhong,and the composition of Chuanxin Tongxiong Prescription is Chuanxiong,whole scorpion,fine spices,safflower,laurel branches,yuanhu,red peony,and tongcao,and the course of treatment is 1 month.SPSS21.0 statistical software was used to process the data,and P<0.05 indicated that the difference was statistically significant.Results:There were no differences in age,sex,duration of disease,basic vital signs,body mass index(BMI),glycated hemoglobin,lipids,C-peptide,lower extremity arterial ultrasound,clinical symptom score,Toronto clinical neuropathy score(TCSS),sensory threshold measurement(VPT),and safety index(P>0.05)before treatment between the two groups of patients,which were comparable.1.Both the control group and the experimental group improved the clinical symptoms(symptoms such as decreased sensation,numbness,pain,coldness,weakness,etc.),but the clinical effect of the experimental group was good.2.Clinical symptom score:P>0.05 in the control group and experimental group before treatment,both the control group and the experimental group could reduce the clinical symptom score,but the post-treatment experimental group(5.17±1.38)had better efficacy than the control group(6.22±1.05)and had obvious differences(P<0.05).3.Toronto clinical neuropathy score:P>0.05 in the control group and experimental group before treatment,and the score can be reduced in both the control group and the experimental group,but the post-treatment experimental group(6.05±1.41a)has better efficacy than the control group(7.89±0.95a),and has obvious differences(P<0.05),which is statistically significant.4.Sensory threshold measurement:P>0.05 in the control group and the experimental group before treatment in the two groups,the control group and the experimental group can reduce the threshold,the sensory threshold measurement test group of the left foot after treatment(16.61±8.06a)has better efficacy than the control group(21.26±8.87a),and the right foot sensory threshold measurement test group(16.8±7.16a)after treatment has better efficacy than the control group(20.66±7.78a).In general,the experimental group had better efficacy than the control group,and there was a significant difference(P<0.05),and the difference was statistically significant.Conclusion:Chuanxin Tong’s prescription directional dialysis therapy has good efficacy in the treatment of diabetic peripheral neuropathy(yang deficiency blood stasis),and the degree of improvement of patients’ clinical symptoms such as "numbness,cold extremities,pain and pain,lower limb weakness or softness" is safe and reliable.